mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.
about
Stem cell guidance through the mechanistic target of rapamycinCutting through the complexities of mTOR for the treatment of strokemTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.Autophagy Plays an Important Role in Anti-inflammatory Mechanisms Stimulated by Alpha7 Nicotinic Acetylcholine ReceptorAzithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.mTOR kinase: a possible pharmacological target in the management of chronic pain.Metabolic Control of Th17 Cell Generation and CNS InflammationTranscriptomic analysis and 3D bioengineering of astrocytes indicate ROCK inhibition produces cytotrophic astrogliosis.A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase B1, is a risk factor for multiple sclerosisInvolvement of phosphatase and tensin homolog deleted from chromosome 10 in rodent model of neuropathic pain.Extracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuliRapamycin protects neurons from brain contusion‑induced inflammatory reaction via modulation of microglial activationMicroglial aging in the healthy CNS: phenotypes, drivers, and rejuvenationMitochondrial deficiency in Cockayne syndrome.Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging.Autophagy in inflammation, infection, neurodegeneration and cancerAutophagy and neurodegenerative disorders.Oligodendrocyte generation during mouse development.Role of autophagy in the pathogenesis of multiple sclerosis.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid.The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.Tripchlorolide ameliorates experimental autoimmune encephalomyelitis by down-regulating ERK1/2-NF-κB and JAK/STAT signaling pathways.mTOR Hyperactivation in down syndrome hippocampus appears early during development.Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory.Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.Effects of intrathecal injection of rapamycin on pain threshold and spinal cord glial activation in rats with neuropathic pain.Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis.
P2860
Q26795544-5F3C027A-5A69-48A3-BA74-DEAF27BC67C5Q26851291-CEC22104-9DAC-438A-8246-FF1BB0804F15Q27312412-BD0EB212-19EC-4009-BD10-2D7503207D2CQ33690026-AA896CF2-027D-43E0-9AA7-65AFE016C30AQ34675784-F5A16078-8132-4F55-A948-964BC18BC084Q34760248-33B19D63-E168-49EC-B75D-9795264737C5Q35035474-4C847D32-3A5B-4EC2-8754-AD6866D940D4Q35101158-219F2F9B-DDE0-4F2B-8281-7098DC0F3F51Q35103816-94A62187-DAEF-4138-888F-F68058EE95B9Q35126302-8D02DFA2-DFFB-474A-BA4A-ADDE7FD7D674Q35276335-B8A18881-2E50-4932-A302-D0B468403925Q35933506-C982072D-C2C2-4E2A-B744-446D9360F777Q36224840-9DA12782-4F99-4385-B6A4-08DF9D254AB3Q36678453-14309A66-D23F-4E37-8E84-95B77BC43445Q36874609-8C34F629-852C-454F-B02C-315A44E4CF48Q37729235-9ED9B903-54DE-4BBB-A6F9-DF6397C2933BQ38164897-958837CA-B796-4B07-BACF-5A1D79AC730BQ38247994-EBE4A3D2-3954-428B-9D81-E1E1735332A1Q38503373-7966DC61-AD2A-408E-B6C6-6061B3528A17Q38562775-5186FFDA-9B82-4581-B44B-812F4443121BQ38607849-A6718089-6D50-42AF-B481-8F9826868728Q38863014-B9C60CC8-021D-466F-A612-8FA953DE6BE2Q38988452-FE5BBA8E-E782-4DC3-8118-6E5D9E898A2EQ42462727-9B0EBCD6-1122-44C1-BC69-F2938CAC3FF9Q42574092-BD14FDEB-264B-416F-9C00-13D99B9F220CQ48338793-4BF05DFA-022B-4BA2-B9E9-879A683C67A9Q48721008-D4B22003-7768-4D39-8509-1F6A649C3490Q50230990-A971933D-7700-4C6D-84AD-CD7DC244230DQ50951186-9F8943CC-AA0A-4B10-BECE-FA4BC440C6F1Q52941274-D841D624-EBF7-47B9-AF86-B9554663740EQ55505818-3D0FC4E8-FD4A-4B8C-9196-26023CC0C6EE
P2860
mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
mTOR kinase, a key player in t ...... therapy of multiple sclerosis.
@en
type
label
mTOR kinase, a key player in t ...... therapy of multiple sclerosis.
@en
prefLabel
mTOR kinase, a key player in t ...... therapy of multiple sclerosis.
@en
P2860
P50
P356
P1433
P1476
mTOR kinase, a key player in t ...... therapy of multiple sclerosis.
@en
P2093
Douglas L Feinstein
P2860
P304
P356
10.1002/GLIA.22433
P577
2012-10-08T00:00:00Z